WE ARE
VITILIGO SPECIALISTS
There is a solution!
![](https://veraskin.com.mx/english/wp-content/uploads/475151898-612x612.jpg)
![](https://veraskin.com.mx/english/wp-content/uploads/vitiligo-2.jpg)
Phototherapy
This involves exposing affected skin to artificial ultraviolet light. Narrow-band Ultraviolet B (NB-UVB) phototherapy is considered the gold standard treatment for vitiligo.
How does it work?
The treatment usually requires a full body unit, where affected skin is exposed from 40 seconds to 5 minutes. 2 to 3 sessions a week are recommended.
Is it safe?
NB-UVB phototherapy is safe when used by qualified providers.
Results
![](https://veraskin.com.mx/english/wp-content/uploads/vit_1_1.jpg)
![](https://veraskin.com.mx/english/wp-content/uploads/vit1_2.jpg)
![](https://veraskin.com.mx/english/wp-content/uploads/vit2_1.jpg)
![](https://veraskin.com.mx/english/wp-content/uploads/vit2_2.jpg)
What our patients say
Andrea Tovar Garza, MD.
Dermatologist
Specializes on:
Pigmentary disorders and vitiligo. Alopecia (hair loss). Aesthetic dermatology.
- Cum Laude. Universidad de Monterrey 2010
- Medical Degree.Universidad de Monterrey, Campus Monterrey 2010
- Training in Dermatological Surgery. Instituto Dermatológico de Jalisco "Dr. José Barba Rubio" 2014
- Training in Medical Mycology. Instituto Dermatológico de Jalisco "Dr. José Barba Rubio"2014
- Training in Cryosurgery. Instituto Dermatológico de Jalisco "Dr. José Barba Rubio"2014
- Clinical and Surgical Dermatology. Instituto Dermatológico de Jalisco "Dr. José Barba Rubio"2016
- Board certified by the Mexican Board of Dermatology. Consejo Mexicano de Dermatología. 2017
- Fellowship in vitiligo and pigmentary disorders University of Texas Southwestern Medical Center, Dallas, Texas.2018
- Training in Hair Disorders (scarring and non-scarring alopecia) Wake Forest University, Winston-Salem, North Carolina.2018
![](https://veraskin.com.mx/english/wp-content/uploads/DRA-ANDREA-TOVAR-VERASKIN.png)
7308427 / 10749894
![](https://veraskin.com.mx/english/wp-content/uploads/Screen-Shot-2022-10-03-at-18.51.28.png)